Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is hidradenocarcinoma?
Hidradenocarcinoma is an uncommon cancer that arises from the sweat glands of the skin — the malignant counterpart of a benign tumor called a hidradenoma. It can appear anywhere on the body as a slowly enlarging nodule, often on the head, neck, or limbs, in middle-aged and older adults. Despite sometimes looking unremarkable, it tends to behave aggressively, with notable rates of local recurrence and spread to lymph nodes or distant sites. Because it is rare and can resemble both benign tumors and skin spread from other cancers, expert dermatopathology is essential, and treatment is built around removing it completely and watching closely.
The main types
Doctors group hidradenocarcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Eccrine hidradenocarcinoma | Derived from the ordinary (eccrine) sweat glands; the more common form. |
| Apocrine hidradenocarcinoma | Shows apocrine-gland features; closely related and managed similarly. |
| Clear-cell hidradenocarcinoma | A microscopic variant with clear-appearing cells that must be told apart from other clear-cell tumors. |
Staging, in plain terms
There is no single rigid stage for this rare cancer; doctors weigh tumor size and depth, microscopic features (how fast the cells divide, invasion of vessels), completeness of removal, and whether lymph nodes are involved.
| Skin-adnexal TNM (size/depth + nodes), individualized | What it generally means |
|---|---|
| Localized, low-risk | Small, completely removed, with reassuring microscopic features; best outlook. |
| Localized, high-risk | Larger, deeper, fast-dividing, or with vessel invasion or close margins; radiation is often added. |
| Node-positive | Has spread to nearby lymph nodes, which are then removed and/or irradiated. |
| Metastatic | Distant spread; managed with chemotherapy and, when present, targeted/hormone receptors, plus radiation for symptom control. |
The standard of care
Hidradenocarcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical excision
Wide local excision with clear margins, or Mohs micrographic surgery for careful margin control, is the cornerstone of treatment.
Lymph node assessment
Because it can reach the nodes, the draining lymph nodes are evaluated and treated if involved.
Radiation and systemic therapy
Radiation for high-risk, recurrent, or unresectable tumors and node disease; chemotherapy, and receptor-targeted therapy when applicable, for advanced cases.
How radiation treatment works
Radiation directs high-energy beams at the tumor to damage the DNA of cancer cells so they can no longer divide, clearing disease that surgery may leave behind. Because hidradenocarcinoma recurs locally and can reach lymph nodes, radiation after surgery improves control for high-risk tumors, and it can serve as the main treatment when surgery isn't possible. The dose is shaped to cover the tumor bed and any at-risk nodes while sparing surrounding healthy skin and structures. Treatment is painless and given over several short daily sessions; a temporary skin reaction in the treated area is the usual side effect.
The main ways radiation is delivered for hidradenocarcinoma:
Adjuvant external-beam radiation
Treats the surgical bed (and nodes when involved) after surgery to lower the high local-recurrence rate seen with this aggressive tumor.
Definitive radiation
For tumors that can't be removed, radiation can be given to a high dose (for example, 70 Gy over about 35 sessions) as the primary treatment.
Systemic therapy (advanced)
Chemotherapy for metastatic disease; tumors that carry hormone or HER2-type receptors may respond to targeted or anti-hormone drugs, identified through pathology testing.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiotherapy for cutaneous adnexal carcinoma: A 20-year, 49-patient single-institution experience supports radiation — after surgery or as definitive treatment — for aggressive sweat-gland cancers including hidradenocarcinoma.[1]
PMC12421330 (2025)
Metastatic apocrine hidradenocarcinoma: Report on managing metastatic disease with chemotherapy and radiation illustrates the multimodal approach needed for advanced tumors.[2]
Rare Tumors (SAGE, 2015)
Adnexal neoplasm diagnosis & treatment review: Review of apocrine/eccrine skin cancers details how expert pathology and combined surgery-plus-radiation guide care for hidradenocarcinoma.[3]
Int. J. Molecular Sciences (MDPI 22:5077)
Common questions
Is hidradenocarcinoma a serious skin cancer? Yes — although rare and sometimes slow-looking, it can behave aggressively, coming back locally and spreading to lymph nodes, so complete removal and close follow-up are important.
Will I need radiation after surgery? Often, for high-risk tumors — those that are large, deep, fast-dividing, removed with close margins, or that involve lymph nodes — radiation after surgery helps prevent it from returning.
What if it can't be completely removed? Radiation can be used as the primary treatment, delivered to a high dose, and systemic therapy is added for disease that has spread.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.